-+ 0.00%
-+ 0.00%
-+ 0.00%

Iovance Biotherapeutics files Form 3 initial beneficial ownership statement for CMO Noah Berkowitz

PUBT·10/02/2026 21:00:48
Listen to the news
Iovance Biotherapeutics files Form 3 initial beneficial ownership statement for CMO Noah Berkowitz
  • Iovance Biotherapeutics filed a Form 3 for Chief Medical Officer Noah Berkowitz tied to his Sept. 30, 2026 start date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iovance Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-113341), on October 02, 2026, and is solely responsible for the information contained therein.